1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SAGE THERAPEUTICS INC
Sage Therapeutics Inc XNAS: SAGE
Momentum Trap

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Sage Therapeutics Inc

The latest disclosure was made by Barry E. Greene in Sage Therapeutics Inc where a trade of 53,229 Common Stock done was reported to US exchanges on July 31, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Barry E. Greene Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 53,229 0 (0%) 0% - Common Stock
Barry E. Greene Director, President and CEO Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 174,000 0 - - Stock Option (Right to Buy)
Barry E. Greene Director, President and CEO 31 Jul 2025 46,940 0 (0%) 0% - Common Stock
James M. Frates Director 31 Jul 2025 2,845 0 (0%) 0% - Common Stock
James M. Frates Director Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 19,154 0 - - Stock Option (Right to Buy)
James M. Frates Director Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 21,500 0 - - Stock Option (Right to Buy)
Geno J. Germano Director Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 21,500 0 - - Stock Option (Right to Buy)
Michael F. Cola Director Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 21,500 0 - - Stock Option (Right to Buy)
George S. Golumbeski Director Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 21,500 0 - - Stock Option (Right to Buy)
George S. Golumbeski Director Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 13,593 0 - - Stock Option (Right to Buy)
George S. Golumbeski Director 31 Jul 2025 8,000 0 (0%) 0% - Common Stock
Elizabeth Barrett Director Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 21,500 0 - - Stock Option (Right to Buy)
Elizabeth Barrett Director 31 Jul 2025 3,000 0 (0%) 0% - Common Stock
Christopher Benecchi Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 36,375 0 (0%) 0% - Common Stock
Christopher Benecchi Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 12,500 0 - - Stock Option (Right to Buy)
Christopher Benecchi Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 40,000 0 - - Stock Option (Right to Buy)
Christopher Benecchi Chief Operating Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 28,053 0 (0%) 0% - Common Stock
Jessica J. Federer Director Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 21,500 0 - - Stock Option (Right to Buy)
Gregory L. Shiferman See Remarks 31 Jul 2025 7,215 0 (0%) 0% - Common Stock
Gregory L. Shiferman See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 28,000 0 - - Stock Option (Right to Buy)
Gregory L. Shiferman See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 10,000 0 - - Stock Option (Right to Buy)
Gregory L. Shiferman See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 23,735 0 (0%) 0% - Common Stock
Mike Quirk See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 4,000 0 - - Stock Option (Right to Buy)
Mike Quirk See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 36,000 0 - - Stock Option (Right to Buy)
Mike Quirk See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 7,962 0 (0%) 0% - Common Stock
Mike Quirk See Remarks Sale or transfer of securities back to the company at price $ 0.00 per share. 31 Jul 2025 24,999 0 (0%) 0% - Common Stock
Gregory L. Shiferman See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.22 per share. 24 Jun 2025 79 30,950 (0%) 0% 9.2 728 Common Stock
Mike Quirk See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.22 per share. 24 Jun 2025 113 30,461 (0%) 0% 9.2 1,042 Common Stock
James M. Frates Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 21,500 21,500 - - Stock Option (Right to Buy)
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 21,500 21,500 - - Stock Option (Right to Buy)
Michael F. Cola Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 21,500 21,500 - - Stock Option (Right to Buy)
George S. Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 21,500 21,500 - - Stock Option (Right to Buy)
Elizabeth Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 21,500 21,500 - - Stock Option (Right to Buy)
Jessica J. Federer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 21,500 21,500 - - Stock Option (Right to Buy)
Barry E. Greene Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. 10 Apr 2025 4,862 100,169 (0%) 0% 6.9 33,596 Common Stock
Barry E. Greene Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2025 19,964 105,031 (0%) 0% 0 Common Stock
Christopher Benecchi Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. 10 Apr 2025 793 46,377 (0%) 0% 6.9 5,480 Common Stock
Christopher Benecchi Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2025 2,712 49,089 (0%) 0% 0 Common Stock
Christopher Benecchi Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2025 3,255 47,170 (0%) 0% 0 Common Stock
Christopher Benecchi Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. 10 Apr 2025 661 48,428 (0%) 0% 6.9 4,568 Common Stock
Gregory L. Shiferman See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2025 525 31,205 (0%) 0% 0 Common Stock
Gregory L. Shiferman See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. 10 Apr 2025 176 31,029 (0%) 0% 6.9 1,216 Common Stock
Mike Quirk See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. 10 Apr 2025 312 29,729 (0%) 0% 6.9 2,156 Common Stock
Mike Quirk See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. 10 Apr 2025 424 30,574 (0%) 0% 6.9 2,930 Common Stock
Mike Quirk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2025 1,269 30,998 (0%) 0% 0 Common Stock
Mike Quirk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2025 933 30,041 (0%) 0% 0 Common Stock
Mike Quirk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2025 4,000 4,000 - - S
Mike Quirk See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2025 2,000 29,108 (0%) 0% 0 Common Stock
Gregory L. Shiferman See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.22 per share. 24 Mar 2025 79 30,680 (0%) 0% 8.2 649 Common Stock
Gregory L. Shiferman See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.49 per share. 24 Feb 2025 2,502 30,759 (0%) 0% 7.5 18,740 Common Stock
Christopher Benecchi Chief Operating Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 13 Feb 2025 822 43,915 (0%) 0% 7.2 5,902 Common Stock
Laura Gault Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 13 Feb 2025 685 34,649 (0%) 0% 7.2 4,918 Common Stock
Gregory L. Shiferman See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 13 Feb 2025 251 33,261 (0%) 0% 7.2 1,802 Common Stock
Gregory L. Shiferman See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. 13 Feb 2025 376 33,512 (0%) 0% 7.2 2,700 Common Stock
Barry E. Greene Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 174,000 174,000 - - Stock Option (Right to Buy)
Christopher Benecchi Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 20,000 44,737 (0%) 0% 0 Common Stock
Christopher Benecchi Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 40,000 40,000 - - Stock Options (Right to buy)
Laura Gault Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 24,000 35,334 (0%) 0% 0 Common Stock
Gregory L. Shiferman See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 14,000 33,888 (0%) 0% 0 Common Stock
Gregory L. Shiferman See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jan 2025 28,000 28,000 - - Stock Option (Right to buy)
James M. Frates Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 19,154 19,154 - - Stock Options (Right to buy)
George S. Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2025 13,593 13,593 - - Stock Options (Right to buy)
Gregory L. Shiferman See Remarks 24 Dec 2024 79 19,888 (0%) 0% 5.5 433 Common Stock
Gregory L. Shiferman See Remarks 01 Nov 2024 5,000 19,967 (0%) 0% 0 Common Stock
Gregory L. Shiferman See Remarks 01 Nov 2024 10,000 10,000 - - Stock Option (Right to buy)
Christopher Benecchi Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2024 12,500 12,500 - - Stock Option (Right to buy)
Christopher Benecchi Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Nov 2024 6,250 24,737 (0%) 0% 0 Common Stock
Barry E. Greene Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2024 50,400 97,340 (0%) 0% 0 Common Stock
Barry E. Greene Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.96 per share. 05 Aug 2024 12,273 85,067 (0%) 0% 9.0 109,966 Common Stock
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2024 13,500 28,543 (0%) 0% 0 Common Stock
Anne Marie Cook SVP, GC & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.96 per share. 05 Aug 2024 4,503 24,040 (0%) 0% 9.0 40,347 Common Stock
Kimi Iguchi CFO & Treasurer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.96 per share. 05 Aug 2024 3,636 81,405 (0%) 0% 9.0 32,579 Common Stock
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2024 13,500 85,041 (0%) 0% 0 Common Stock
Christopher Benecchi Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.96 per share. 05 Aug 2024 4,755 18,487 (0%) 0% 9.0 42,605 Common Stock
Christopher Benecchi Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2024 16,200 23,242 (0%) 0% 0 Common Stock
Laura Gault Chief Medical Officer 05 Aug 2024 3,288 10,737 (0%) 0% 9.0 29,460 Common Stock
Laura Gault Chief Medical Officer 05 Aug 2024 13,500 14,025 (0%) 0% 0 Common Stock
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 12,500 12,500 - - Stock Option (Right to Buy)
James M. Frates Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 12,500 12,500 - - Stock Option (Right to Buy)
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 12,500 12,500 - - Stock Option (Right to Buy)
Michael F. Cola Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 12,500 12,500 - - Stock Option (Right to Buy)
George Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 12,500 12,500 - - Stock Option (Right to Buy)
Elizabeth Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 12,500 12,500 - - Stock Option (Right to Buy)
Jessica J. Federer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2024 12,500 12,500 - - Stock Option (Right to Buy)
Christopher Benecchi Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2024 13,500 19,430 (0%) 0% 0 Common Stock
Christopher Benecchi Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2024 27,000 27,000 - - Stock Option (Right to Buy)
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2024 22,500 22,500 - - Stock Option (Right to Buy)
Laura Gault Chief Medical Officer 13 Feb 2024 11,250 11,477 (0%) 0% 0 Common Stock
Barry E. Greene Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2024 168,000 168,000 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2024 11,250 81,679 (0%) 0% 0 Common Stock
Laura Gault Chief Medical Officer 13 Feb 2024 22,500 22,500 - - Stock Option (Right to Buy)
Marie Anne Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2024 11,250 25,181 (0%) 0% 0 Common Stock
Iguchi Kimi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2024 22,500 22,500 - - Stock Option (Right to Buy)
M. Steve Paul Director 03 Jan 2024 3,971 3,971 - - Stock Options (Right to buy)
Golumbeski George Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2024 3,495 3,495 - - Stock Options (Right to buy)
M. Frates James Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2024 4,925 4,925 - - Stock Options (Right to buy)
J. Jessica Federer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2024 3,177 3,177 - - Stock Options (Right to buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 02 Jan 2024 1,642 70,429 (0%) 0% 1.4 2,233 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2024 1,642 0 - - Stock Option (Right to Buy)
Elizabeth Barrett Director Purchase of securities on an exchange or from another person at price $ 18.64 per share. 09 Aug 2023 2,000 3,000 (0%) 0% 18.6 37,279 Common Stock
Barry E. Greene Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2023 195,000 195,000 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 10,000 10,000 - - Stock Option (Right to Buy)
James M. Frates Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 10,000 10,000 - - Stock Option (Right to Buy)
Steve M. Paul Director 15 Jun 2023 10,000 10,000 - - Stock Option (Right to Buy)
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 10,000 10,000 - - Stock Option (Right to Buy)
Kevin P. Starr Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 10,000 10,000 - - Stock Option (Right to Buy)
Michael F. Cola Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 10,000 10,000 - - Stock Option (Right to Buy)
George Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 10,000 10,000 - - Stock Option (Right to Buy)
Elizabeth Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 10,000 10,000 - - Stock Option (Right to Buy)
Jessica J. Federer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2023 10,000 10,000 - - Stock Option (Right to Buy)
Elizabeth Barrett Director Purchase of securities on an exchange or from another person at price $ 50.50 per share. 09 May 2023 1,000 1,000 (0%) 0% 50.5 50,500 Common Stock
Jessica J. Federer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2023 19,894 19,894 - - Stock Options (Right to buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2023 3,000 1,642 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 15 Mar 2023 3,000 65,560 (0%) 0% 1.4 4,080 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 21 Feb 2023 750 62,310 (0%) 0% 1.4 1,020 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2023 250 4,642 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Feb 2023 750 4,892 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 21 Feb 2023 250 62,560 (0%) 0% 1.4 340 Common Stock
Barry E. Greene Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2023 66,500 66,500 - - Stock Option (Right to Buy)
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2023 19,000 19,000 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2023 16,720 16,720 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2023 16,720 16,720 - - Stock Option (Right to Buy)
Christopher Benecchi Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2023 20,900 20,900 - - Stock Option (Right to Buy)
Laura Gault Chief Medical Officer 13 Feb 2023 2,660 2,660 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 10 Feb 2023 11,643 133,624 (0%) 0% 0.4 5,239 Common Stock
Jeffrey M. Jonas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Feb 2023 11,643 0 - - Stock Options (Right to buy)
Jeffrey M. Jonas Director Sale of securities on an exchange or to another person at price $ 44.90 per share. 10 Feb 2023 3,838 121,981 (0%) 0% 44.9 172,329 Common Stock
Jeffrey M. Jonas Director Sale of securities on an exchange or to another person at price $ 44.47 per share. 10 Feb 2023 7,805 125,819 (0%) 0% 44.5 347,084 Common Stock
Anne Marie Cook SVP, GC & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.16 per share. 03 Feb 2023 980 10,498 (0%) 0% 44.2 43,277 Common Stock
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 2,850 11,478 (0%) 0% 0 Common Stock
Jeffrey M. Jonas Director Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.16 per share. 03 Feb 2023 1,427 121,981 (0%) 0% 44.2 63,016 Common Stock
Jeffrey M. Jonas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 5,100 123,408 (0%) 0% 0 Common Stock
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 2,850 62,474 (0%) 0% 0 Common Stock
Kimi Iguchi CFO & Treasurer Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.16 per share. 03 Feb 2023 914 61,560 (0%) 0% 44.2 40,362 Common Stock
Albert J. Robichaud Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.16 per share. 03 Feb 2023 1,127 145,553 (0%) 0% 44.2 49,768 Common Stock
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 3,375 146,680 (0%) 0% 0 Common Stock
Christopher Benecchi Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.16 per share. 03 Feb 2023 2,119 5,260 (0%) 0% 44.2 93,575 Common Stock
Christopher Benecchi Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2023 6,750 7,379 (0%) 0% 0 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jan 2023 1,600 5,642 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 09 Jan 2023 1,600 59,624 (0%) 0% 1.4 2,176 Common Stock
Steve M. Paul Director 04 Jan 2023 2,395 2,395 - - Stock Options (Right to buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2023 1,800 7,242 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 04 Jan 2023 1,800 58,024 (0%) 0% 1.4 2,448 Common Stock
George Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2023 2,108 2,108 - - Stock Options (Right to buy)
Jeffrey M. Jonas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2023 2,501 57,499 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.63 per share. 03 Jan 2023 2,501 118,308 (0%) 0% 28.6 71,604 Common Stock
Steve M. Paul Director 28 Nov 2022 5 78,539 (0%) 0% 38.2 191 Common Stock
Barry E. Greene Director, President and CEO Purchase of securities on an exchange or from another person at price $ 34.48 per share. 10 Nov 2022 14,500 46,940 (0%) 0% 34.5 500,022 Common Stock
Laura Gault Chief Medical Officer 01 Nov 2022 64,410 64,410 - - Stock Option (Right to Buy)
James M. Frates Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 9,947 9,947 - - Stock Option (Right to Buy)
Steve M. Paul Director 16 Jun 2022 9,947 9,947 - - Stock Option (Right to Buy)
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 9,947 9,947 - - Stock Option (Right to Buy)
Kevin P. Starr Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 9,947 9,947 - - Stock Option (Right to Buy)
Michael F. Cola Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 9,947 9,947 - - Stock Option (Right to Buy)
George Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 9,947 9,947 - - Stock Option (Right to Buy)
Elizabeth Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 9,947 9,947 - - Stock Option (Right to Buy)
Christopher Benecchi Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 9,500 9,500 - - Stock Options (Right to buy)
George Golumbeski Director Purchase of securities on an exchange or from another person at price $ 31.45 per share. 05 May 2022 8,000 8,000 (0%) 0% 31.4 251,563 Common Stock
Jeffrey M. Jonas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Apr 2022 30,944 11,643 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 27 Apr 2022 30,944 115,807 (0%) 0% 0.5 13,925 Common Stock
Jeffrey M. Jonas Director, Chief Innovation Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 17 Feb 2022 4,000 84,863 (0%) 0% 0.5 1,800 Common Stock
Jeffrey M. Jonas Director, Chief Innovation Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Feb 2022 4,000 42,587 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 17 Feb 2022 4,500 55,600 (0%) 0% 1.4 6,120 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Feb 2022 4,500 9,042 - - Stock Option (Right to Buy)
Barry E. Greene Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 69,920 69,920 - - Stock Option (Right to Buy)
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 15,200 15,200 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 15,200 15,200 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 15,200 15,200 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 13,300 13,300 - - Stock Option (Right to Buy)
Christopher Benecchi Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 11,400 11,400 - - Stock Option (Right to Buy)
Steve M. Paul Director 04 Jan 2022 1,638 1,638 - - Stock Options (Right to buy)
George Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 1,638 1,638 - - Stock Options (Right to buy)
Elizabeth Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 2,048 2,048 - - Stock Options (Right to buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Nov 2021 2,500 495 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 22 Nov 2021 1,000 51,100 (0%) 0% 1.4 1,360 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 22 Nov 2021 2,500 50,100 (0%) 0% 1.4 3,400 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Nov 2021 505 13,542 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Nov 2021 495 0 - - Stock Option (Right to Buy)
Steven M. Paul Director 09 Nov 2021 1 1 (0%) 0% 43 43 Common Stock
Anne Marie Cook SVP, GC & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.29 per share. 19 Oct 2021 1,116 7,894 (0%) 0% 40.3 44,964 Common Stock
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Oct 2021 3,800 9,010 (0%) 0% 0 Common Stock
Jeffrey M. Jonas Director, Chief Innovation Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.29 per share. 19 Oct 2021 4,374 80,863 (0%) 0% 40.3 176,228 Common Stock
Jeffrey M. Jonas Director, Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Oct 2021 10,000 85,237 (0%) 0% 0 Common Stock
Kimi Iguchi CFO & Treasurer Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.29 per share. 19 Oct 2021 1,024 47,600 (0%) 0% 40.3 41,257 Common Stock
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Oct 2021 3,800 48,624 (0%) 0% 0 Common Stock
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Oct 2021 3,800 14,591 (0%) 0% 0 Common Stock
Stephen J. Kanes Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.29 per share. 19 Oct 2021 1,120 13,471 (0%) 0% 40.3 45,125 Common Stock
Albert J. Robichaud Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.29 per share. 19 Oct 2021 1,116 142,619 (0%) 0% 40.3 44,964 Common Stock
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Oct 2021 3,800 143,735 (0%) 0% 0 Common Stock
Christopher Benecchi Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 45,000 45,000 - - Stock Option (Right to Buy)
Barry E. Greene Director, President and CEO Purchase of securities on an exchange or from another person at price $ 43.15 per share. 05 Aug 2021 23,640 32,440 (0%) 0% 43.1 1,020,054 Common Stock
Barry E. Greene Director, President and CEO Purchase of securities on an exchange or from another person at price $ 56.32 per share. 16 Jun 2021 8,800 8,800 (0%) 0% 56.3 495,627 Common Stock
James M. Frates Director Purchase of securities on an exchange or from another person at price $ 55.10 per share. 16 Jun 2021 1,810 1,810 (0%) 0% 55.1 99,735 Common Stock
Kevin P. Starr Director Purchase of securities on an exchange or from another person at price $ 56.05 per share. 16 Jun 2021 17,842 320,659 (0%) 0% 56.0 999,983 Common Stock
Anne Marie Cook SVP, GC & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.80 per share. 15 Jun 2021 1,144 4,973 (0%) 0% 58.8 67,267 Common Stock
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 4,000 6,117 (0%) 0% 0 Common Stock
Jeffrey M. Jonas Director, Chief Innovation Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 15 Jun 2021 12,000 75,237 (0%) 0% 0.5 5,400 Common Stock
Jeffrey M. Jonas Director, Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 10,000 66,330 (0%) 0% 0 Common Stock
Jeffrey M. Jonas Director, Chief Innovation Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.80 per share. 15 Jun 2021 3,093 63,237 (0%) 0% 58.8 181,868 Common Stock
Jeffrey M. Jonas Director, Chief Innovation Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 12,000 46,587 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 3,500 43,355 (0%) 0% 0 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 3,000 16,047 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 15 Jun 2021 2,000 44,533 (0%) 0% 1.4 2,720 Common Stock
Kimi Iguchi CFO & Treasurer Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.80 per share. 15 Jun 2021 822 42,533 (0%) 0% 58.8 48,334 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 15 Jun 2021 3,000 39,855 (0%) 0% 1.4 4,080 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2021 2,000 14,047 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.80 per share. 15 Jun 2021 1,001 10,791 (0%) 0% 58.8 58,859 Common Stock
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 3,500 11,792 (0%) 0% 0 Common Stock
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2021 4,000 140,795 (0%) 0% 0 Common Stock
Albert J. Robichaud Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.80 per share. 15 Jun 2021 1,144 139,651 (0%) 0% 58.8 67,267 Common Stock
James M. Frates Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Steven M. Paul Director 10 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Geno J. Germano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Kevin P. Starr Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Michael F. Cola Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
George Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Elizabeth Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 13 Apr 2021 1,500 36,855 (0%) 0% 1.4 2,040 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2021 948 0 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2021 552 2,995 - - Stock Option (Right to Buy)
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2021 19,000 19,000 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, Chief Innovation Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2021 34,000 34,000 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2021 19,000 19,000 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2021 19,000 19,000 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2021 22,500 22,500 - - Stock Option (Right to Buy)
Michael Cloonan Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2021 19,000 19,000 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, Chief Innovation Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2021 1,800 58,587 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, Chief Innovation Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 27 Jan 2021 1,800 56,330 (0%) 0% 0.5 810 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 05 Jan 2021 1,750 35,355 (0%) 0% 1.4 2,380 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jan 2021 1,750 948 - - Stock Option (Right to Buy)
George Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 832 832 - - Stock Options (Right to buy)
Elizabeth Barrett Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2021 915 915 - - Stock Options (Right to buy)
Barry E. Greene Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 390,000 390,000 - - Stock Options (Right to buy)
James M. Frates None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2020 10,000 10,000 - - Stock Option (Right to Buy)
Steven M. Paul None 09 Jun 2020 10,000 10,000 - - Stock Option (Right to Buy)
Geno J. Germano None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2020 10,000 10,000 - - Stock Option (Right to Buy)
Kevin P. Starr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2020 10,000 10,000 - - Stock Option (Right to Buy)
Michael F. Cola None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2020 10,000 10,000 - - Stock Option (Right to Buy)
George Golumbeski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2020 10,000 10,000 - - Stock Option (Right to Buy)
Elizabeth Barrett None Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2020 10,000 10,000 - - Stock Option (Right to Buy)
Michael Cloonan Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2020 50,000 50,000 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2020 4,000 2,698 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 30 Apr 2020 4,000 33,261 (0%) 0% 1.4 5,440 Common Stock
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2020 9,450 9,450 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2020 15,385 15,385 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2020 9,450 9,450 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2020 9,450 9,450 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2020 9,450 9,450 - - Stock Option (Right to Buy)
Michael Cloonan Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2020 9,450 9,450 - - Stock Option (Right to Buy)
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 20,000 20,000 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 50,000 50,000 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 17,500 17,500 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 17,500 17,500 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 20,000 20,000 - - Stock Option (Right to Buy)
Michael Cloonan Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2020 22,500 22,500 - - Stock Option (Right to Buy)
George Golumbeski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2020 976 976 - - Stock Options (Right to buy)
Jeffrey M. Jonas Director, President & CEO Purchase of securities on an exchange or from another person at price $ 64.20 per share. 09 Dec 2019 7,500 54,530 (0%) 0% 64.2 481,500 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2019 500 3,547 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2019 15,000 4,047 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 09 Dec 2019 500 29,261 (0%) 0% 1.4 680 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 09 Dec 2019 15,000 28,761 (0%) 0% 1.4 20,400 Common Stock
Albert J. Robichaud Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2019 3,076 21,924 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2019 5,732 32,668 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Dec 2019 6,935 0 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 64.16 per share. 09 Dec 2019 25,000 136,400 (0%) 0% 64.2 1,604,000 Common Stock
Albert J. Robichaud Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.63 per share. 09 Dec 2019 3,076 111,400 (0%) 0% 28.6 88,066 Common Stock
Albert J. Robichaud Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.25 per share. 09 Dec 2019 5,732 108,324 (0%) 0% 38.3 219,249 Common Stock
Albert J. Robichaud Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 09 Dec 2019 6,935 102,592 (0%) 0% 1.4 9,432 Common Stock
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Sep 2019 4,600 60,387 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 11 Sep 2019 4,600 47,030 (0%) 0% 0.5 2,070 Common Stock
Stephen J. Kanes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Sep 2019 6,000 86,100 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 04 Sep 2019 6,000 8,292 (0%) 0% 0.5 2,700 Common Stock
James M. Frates None Gift of securities by or to the insider at price $ 0.00 per share. 15 Aug 2019 500 2,535 (0%) 0% 0 Common Stock
James M. Frates None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2019 8,000 5,922 - - Stock Option (Right to Buy)
James M. Frates None Sale of securities on an exchange or to another person at price $ 160.58 per share. 15 Aug 2019 8,000 2,535 (0%) 0% 160.6 1,284,640 Common Stock
James M. Frates None Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.35 per share. 15 Aug 2019 8,000 10,535 (0%) 0% 28.4 226,800 Common Stock
James M. Frates None Gift of securities by or to the insider at price $ 0.00 per share. 15 Aug 2019 1,200 3,035 (0%) 0% 0 Common Stock
Anne Marie Cook SVP, GC & Secretary Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.38 per share. 25 Jul 2019 844 1,756 (0%) 0% 161.4 136,205 Common Stock
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2019 1,900 2,600 (0%) 0% 0 Common Stock
Jeffrey M. Jonas Director, President & CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.38 per share. 25 Jul 2019 1,685 42,430 (0%) 0% 161.4 271,925 Common Stock
Jeffrey M. Jonas Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2019 5,000 44,115 (0%) 0% 0 Common Stock
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2019 1,900 14,309 (0%) 0% 0 Common Stock
Kimi Iguchi CFO & Treasurer Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.38 per share. 25 Jul 2019 548 13,761 (0%) 0% 161.4 88,436 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jul 2019 2,000 6,698 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 25 Jul 2019 2,000 12,409 (0%) 0% 1.4 2,720 Common Stock
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2019 1,900 2,841 (0%) 0% 0 Common Stock
Stephen J. Kanes Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.38 per share. 25 Jul 2019 549 2,292 (0%) 0% 161.4 88,598 Common Stock
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2019 1,900 96,205 (0%) 0% 0 Common Stock
Albert J. Robichaud Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 25 Jul 2019 825 94,137 (0%) 0% 0 Common Stock
Albert J. Robichaud Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.38 per share. 25 Jul 2019 548 95,657 (0%) 0% 161.4 88,436 Common Stock
Michael Cloonan Chief Business Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.38 per share. 25 Jul 2019 1,088 2,102 (0%) 0% 161.4 175,581 Common Stock
Michael Cloonan Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2019 2,450 3,190 (0%) 0% 0 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Jul 2019 4,000 8,698 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.36 per share. 17 Jul 2019 4,000 10,409 (0%) 0% 1.4 5,440 Common Stock
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jul 2019 27,000 64,987 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 16 Jul 2019 27,000 39,115 (0%) 0% 0.5 12,150 Common Stock
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2019 9,240 18,480 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2019 23,100 46,200 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2019 7,425 14,850 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2019 6,600 13,200 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2019 6,600 13,200 - - Stock Option (Right to Buy)
James M. Frates None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Steven M. Paul None 05 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Geno J. Germano None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Kevin P. Starr None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Michael F. Cola None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
George Golumbeski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Asha Nayak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Elizabeth Barrett None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 171.01 per share. 23 May 2019 500 115,523 (0%) 0% 171.0 85,505 Common Stock
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 23 May 2019 53,908 116,023 (0%) 0% 0.5 24,259 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 172.20 per share. 23 May 2019 1,619 113,904 (0%) 0% 172.2 278,792 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 173.41 per share. 23 May 2019 4,200 109,704 (0%) 0% 173.4 728,322 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 174.46 per share. 23 May 2019 31,099 78,605 (0%) 0% 174.5 5,425,532 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 175.09 per share. 23 May 2019 14,727 63,878 (0%) 0% 175.1 2,578,550 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 176.15 per share. 23 May 2019 1,763 62,115 (0%) 0% 176.1 310,552 Common Stock
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 23 May 2019 40,356 102,471 (0%) 0% 0.4 18,160 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 174.05 per share. 23 May 2019 7,948 94,523 (0%) 0% 174.0 1,383,349 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 175.02 per share. 23 May 2019 24,966 69,557 (0%) 0% 175.0 4,369,549 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 175.79 per share. 23 May 2019 3,974 65,583 (0%) 0% 175.8 698,589 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 176.80 per share. 23 May 2019 2,518 63,065 (0%) 0% 176.8 445,182 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 177.76 per share. 23 May 2019 950 62,115 (0%) 0% 177.8 168,872 Common Stock
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 May 2019 53,908 168,079 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 May 2019 40,356 127,723 - - Stock Option (Right to Buy)
Michael Cloonan Chief Business Officer Sale of securities on an exchange or to another person at price $ 175.00 per share. 22 May 2019 25,000 461 (0%) 0% 175 4,375,000 Common Stock
Michael Cloonan Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.43 per share. 22 May 2019 25,000 25,461 (0%) 0% 73.4 1,835,750 Common Stock
Michael Cloonan Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 May 2019 25,000 160,000 - - Stock Option (Right to Buy)
Anne Marie Cook SVP, GC & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.27 per share. 10 May 2019 700 700 (0%) 0% 56.3 39,389 Common Stock
Anne Marie Cook SVP, GC & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.63 per share. 10 May 2019 15,000 15,000 (0%) 0% 28.6 429,450 Common Stock
Anne Marie Cook SVP, GC & Secretary Sale of securities on an exchange or to another person at price $ 166.14 per share. 10 May 2019 15,000 0 (0%) 0% 166.1 2,492,100 Common Stock
Anne Marie Cook SVP, GC & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2019 700 109,300 - - Stock Option (Right to Buy)
Anne Marie Cook SVP, GC & Secretary Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 May 2019 15,000 15,000 - - Stock Option (Right to Buy)
Steven M. Paul None 21 Mar 2019 2,993 127,286 (0%) 0% 161.0 481,993 Common Stock
Steven M. Paul None 21 Mar 2019 1,967 122,400 (0%) 0% 161.0 316,726 Common Stock
Steven M. Paul None 21 Mar 2019 2,919 124,367 (0%) 0% 161.1 470,105 Common Stock
Steven M. Paul None 18 Mar 2019 900 189,800 (0%) 0% 161.0 144,909 Common Stock
Steven M. Paul None 18 Mar 2019 13,047 130,279 (0%) 0% 161.3 2,105,133 Common Stock
Steven M. Paul None 18 Mar 2019 13,096 143,326 (0%) 0% 161.3 2,112,647 Common Stock
Steven M. Paul None 18 Mar 2019 16,182 156,422 (0%) 0% 161.2 2,608,538 Common Stock
Steven M. Paul None 18 Mar 2019 14,321 172,604 (0%) 0% 161.3 2,310,264 Common Stock
Steven M. Paul None 18 Mar 2019 875 186,925 (0%) 0% 161.0 140,884 Common Stock
Steven M. Paul None 18 Mar 2019 800 187,800 (0%) 0% 161.0 128,816 Common Stock
Steven M. Paul None 18 Mar 2019 1,200 188,600 (0%) 0% 161.1 193,368 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Mar 2019 4,723 0 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 08 Mar 2019 4,723 6,136 (0%) 0% 0.4 2,125 Common Stock
Steven M. Paul None 01 Mar 2019 700 190,700 (0%) 0% 161 112,700 Common Stock
Steven M. Paul None 01 Mar 2019 700 191,400 (0%) 0% 161 112,700 Common Stock
Steven M. Paul None 01 Mar 2019 500 192,100 (0%) 0% 161 80,500 Common Stock
Steven M. Paul None 01 Mar 2019 700 192,600 (0%) 0% 161 112,700 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 156.93 per share. 01 Mar 2019 25,563 1,413 (0%) 0% 156.9 4,011,602 Common Stock
Steven M. Paul None 25 Feb 2019 500 72,400 (0%) 0% 161 80,500 Common Stock
Steven M. Paul None 25 Feb 2019 30,600 193,300 (0%) 0% 0 Common Stock
Steven M. Paul None 25 Feb 2019 30,600 162,700 (0%) 0% 0 Common Stock
Steven M. Paul None 25 Feb 2019 30,600 132,100 (0%) 0% 0 Common Stock
Steven M. Paul None 25 Feb 2019 30,600 101,500 (0%) 0% 0 Common Stock
Steven M. Paul None 25 Feb 2019 122,400 119,295 (0%) 0% 0 Common Stock
Steven M. Paul None 25 Feb 2019 500 70,900 (0%) 0% 161 80,500 Common Stock
Steven M. Paul None 25 Feb 2019 500 71,400 (0%) 0% 161 80,500 Common Stock
Steven M. Paul None 25 Feb 2019 500 71,900 (0%) 0% 161 80,500 Common Stock
Steven M. Paul None 15 Feb 2019 241,695 272,777 (0%) 0% 0 Common Stock
Steven M. Paul None 15 Feb 2019 200 72,900 (0%) 0% 162 32,400 Common Stock
Steven M. Paul None 15 Feb 2019 643 73,100 (0%) 0% 161.4 103,761 Common Stock
Steven M. Paul None 15 Feb 2019 500 73,743 (0%) 0% 161.6 80,812 Common Stock
Steven M. Paul None 15 Feb 2019 200 74,243 (0%) 0% 162 32,400 Common Stock
Steven M. Paul None 15 Feb 2019 12,388 74,443 (0%) 0% 161.0 1,994,716 Common Stock
Steven M. Paul None 15 Feb 2019 12,044 86,831 (0%) 0% 161.0 1,939,325 Common Stock
Steven M. Paul None 15 Feb 2019 12,510 98,875 (0%) 0% 161.0 2,014,360 Common Stock
Steven M. Paul None 15 Feb 2019 12,519 111,385 (0%) 0% 161.0 2,015,809 Common Stock
Steven M. Paul None 15 Feb 2019 241,695 241,695 (0%) 0% 0 Common Stock
Anne Marie Cook SVP, GC & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 19,000 19,000 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 50,000 50,000 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 19,000 19,000 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 19,000 19,000 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 19,000 19,000 - - Stock Option (Right to Buy)
Michael Cloonan Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2019 24,500 24,500 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 150.00 per share. 08 Feb 2019 22,948 941 (0%) 0% 150 3,442,200 Common Stock
James M. Frates None Sale of securities on an exchange or to another person at price $ 134.81 per share. 23 Jan 2019 7,500 4,235 (0%) 0% 134.8 1,011,075 Common Stock
James M. Frates None Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.92 per share. 23 Jan 2019 7,500 11,735 (0%) 0% 8.9 66,900 Common Stock
James M. Frates None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jan 2019 7,500 9,309 - - Stock Option (Right to Buy)
George Golumbeski None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2019 20,000 20,000 - - Stock Options (Right to buy)
Elizabeth Barrett None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2019 20,000 20,000 - - Stock Options (Right to buy)
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jan 2019 10,000 221,987 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 09 Jan 2019 10,000 62,115 (0%) 0% 0.5 4,500 Common Stock
Geno J. Germano None Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2019 878 878 - - Stock Option (Right to Buy)
Steven M. Paul None 31 Dec 2018 123,904 123,904 (0%) 0% 0 Common Stock
Steven M. Paul None 31 Dec 2018 121,035 514,472 (1%) 0% 0 Common Stock
Steven M. Paul None 31 Dec 2018 121,035 123,904 (0%) 0% 0 Common Stock
Steven M. Paul None 31 Dec 2018 123,904 0 (0%) 0% 0 Common Stock
Albert J. Robichaud Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 31 Dec 2018 875 94,962 (0%) 0% 0 Common Stock
Anne Marie Cook See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2018 9,240 9,240 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2018 23,100 23,100 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2018 7,425 7,425 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2018 6,600 6,600 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2018 6,600 6,600 - - Stock Option (Right to Buy)
James M. Frates None Gift of securities by or to the insider at price $ 0.00 per share. 22 Aug 2018 65 4,235 (0%) 0% 0 Common Stock
James M. Frates None Gift of securities by or to the insider at price $ 0.00 per share. 22 Aug 2018 700 4,300 (0%) 0% 0 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 19 Jun 2018 800 26,826 (0%) 0% 0.5 360 Common Stock
Kimi Iguchi CFO & Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jun 2018 800 67,949 - - Stock Option (Right to Buy)
James M. Frates None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Steven M. Paul None 06 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Geno J. Germano None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Kevin P. Starr Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Michael F. Cola None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Asha Nayak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
James M. Frates None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 May 2018 7,000 16,809 - - Stock Option (Right to Buy)
James M. Frates None Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.92 per share. 08 May 2018 7,000 12,000 (0%) 0% 8.9 62,440 Common Stock
James M. Frates None Sale of securities on an exchange or to another person at price $ 154.00 per share. 08 May 2018 7,000 5,000 (0%) 0% 154 1,078,000 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 143.09 per share. 26 Apr 2018 3,207 35,038 (0%) 0% 143.1 458,890 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 141.21 per share. 26 Apr 2018 100 38,245 (0%) 0% 141.2 14,121 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 143.90 per share. 26 Apr 2018 3,300 31,738 (0%) 0% 143.9 474,870 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 144.98 per share. 26 Apr 2018 6,075 25,663 (0%) 0% 145.0 880,754 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 145.80 per share. 26 Apr 2018 100 25,563 (0%) 0% 145.8 14,580 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 141.26 per share. 23 Apr 2018 2,300 39,245 (0%) 0% 141.3 324,898 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 142.69 per share. 23 Apr 2018 900 38,345 (0%) 0% 142.7 128,421 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 142.84 per share. 23 Apr 2018 2,999 63,499 (0%) 0% 142.8 428,377 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 143.90 per share. 23 Apr 2018 4,700 58,799 (0%) 0% 143.9 676,330 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 144.71 per share. 23 Apr 2018 2,601 56,198 (0%) 0% 144.7 376,391 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 145.58 per share. 23 Apr 2018 700 55,498 (0%) 0% 145.6 101,906 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 149.54 per share. 23 Apr 2018 635 54,863 (0%) 0% 149.5 94,958 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 150.68 per share. 23 Apr 2018 500 54,363 (0%) 0% 150.7 75,340 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 141.51 per share. 23 Apr 2018 2,500 51,863 (0%) 0% 141.5 353,775 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 142.50 per share. 23 Apr 2018 900 50,963 (0%) 0% 142.5 128,250 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 144.06 per share. 23 Apr 2018 500 50,463 (0%) 0% 144.1 72,030 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 145.10 per share. 23 Apr 2018 600 49,863 (0%) 0% 145.1 87,060 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 146.14 per share. 23 Apr 2018 500 49,363 (0%) 0% 146.1 73,070 Common Stock
Kimi Iguchi CFO & Treasurer Sale of securities on an exchange or to another person at price $ 140.38 per share. 23 Apr 2018 7,818 41,545 (0%) 0% 140.4 1,097,491 Common Stock
Kevin P. Starr None Sale of securities on an exchange or to another person at price $ 169.25 per share. 17 Apr 2018 35,000 326,817 (0%) 0% 169.2 5,923,600 Common Stock
Kevin P. Starr None Sale of securities on an exchange or to another person at price $ 168.28 per share. 17 Apr 2018 24,000 302,817 (0%) 0% 168.3 4,038,650 Common Stock
Anne Marie Cook Senior VP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2018 31,500 31,500 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2018 90,000 90,000 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2018 31,500 31,500 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2018 27,000 27,000 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2018 31,500 31,500 - - Stock Option (Right to Buy)
Michael Cloonan Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Apr 2018 36,000 36,000 - - Stock Option (Right to Buy)
Steven M. Paul None 06 Mar 2018 58,139 632,712 (1%) 0% 172 9,999,908 Common Stock
Kevin P. Starr None Other type of transaction at price $ 0.00 per share. 16 Feb 2018 510,554 37,362 (0%) 1% 0 Common Stock
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 173.09 per share. 10 Jan 2018 1,200 43,948 (0%) 0% 173.1 207,708 Common Stock
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 175.03 per share. 10 Jan 2018 2,461 39,287 (0%) 0% 175.0 430,749 Common Stock
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 176.53 per share. 10 Jan 2018 11,057 28,230 (0%) 0% 176.5 1,951,892 Common Stock
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 177.48 per share. 10 Jan 2018 9,100 19,130 (0%) 0% 177.5 1,615,068 Common Stock
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 178.33 per share. 10 Jan 2018 6,923 12,207 (0%) 0% 178.3 1,234,579 Common Stock
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 179.61 per share. 10 Jan 2018 7,859 4,348 (0%) 0% 179.6 1,411,555 Common Stock
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 180.11 per share. 10 Jan 2018 1,400 2,948 (0%) 0% 180.1 252,154 Common Stock
Stephen J. Kanes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 10 Jan 2018 20,000 22,948 (0%) 0% 0.5 9,000 Common Stock
Stephen J. Kanes Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jan 2018 20,000 111,432 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 170.67 per share. 10 Jan 2018 600 46,348 (0%) 0% 170.7 102,402 Common Stock
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 171.80 per share. 10 Jan 2018 1,200 45,148 (0%) 0% 171.8 206,160 Common Stock
Stephen J. Kanes Chief Medical Officer Sale of securities on an exchange or to another person at price $ 174.35 per share. 10 Jan 2018 2,200 41,748 (0%) 0% 174.4 383,570 Common Stock
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 26 Dec 2017 50,000 51,226 (0%) 0% 0.5 22,500 Common Stock
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Dec 2017 50,000 232,552 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 155.00 per share. 21 Dec 2017 12,753 1,226 (0%) 0% 155 1,976,715 Common Stock
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 21 Dec 2017 12,753 13,979 (0%) 0% 0.5 5,739 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 162.59 per share. 21 Dec 2017 599 1,226 (0%) 0% 162.6 97,391 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 162.08 per share. 21 Dec 2017 5,000 1,825 (0%) 0% 162.1 810,400 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 160.36 per share. 21 Dec 2017 13,049 6,825 (0%) 0% 160.4 2,092,538 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 159.53 per share. 21 Dec 2017 22,334 19,874 (0%) 0% 159.5 3,562,943 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 158.21 per share. 21 Dec 2017 33,301 42,208 (0%) 0% 158.2 5,268,551 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 157.48 per share. 21 Dec 2017 27,152 75,509 (0%) 0% 157.5 4,275,897 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 156.55 per share. 21 Dec 2017 71,823 102,661 (0%) 0% 156.6 11,243,891 Common Stock
Jeffrey M. Jonas Director, President & CEO Sale of securities on an exchange or to another person at price $ 155.48 per share. 21 Dec 2017 36,989 174,484 (0%) 0% 155.5 5,751,050 Common Stock
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2017 110,247 295,305 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2017 12,753 282,552 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.45 per share. 21 Dec 2017 110,247 211,473 (0%) 0% 0.4 49,611 Common Stock
Albert J. Robichaud Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 156.31 per share. 14 Dec 2017 1,500 152,759 (0%) 0% 156.3 234,465 Common Stock
Albert J. Robichaud Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 157.27 per share. 14 Dec 2017 3,700 149,059 (0%) 0% 157.3 581,899 Common Stock
Albert J. Robichaud Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 163.93 per share. 14 Dec 2017 1,021 94,259 (0%) 0% 163.9 167,373 Common Stock
Albert J. Robichaud Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 162.21 per share. 14 Dec 2017 700 95,280 (0%) 0% 162.2 113,547 Common Stock
Albert J. Robichaud Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 161.40 per share. 14 Dec 2017 6,187 95,980 (0%) 0% 161.4 998,582 Common Stock
Albert J. Robichaud Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 160.12 per share. 14 Dec 2017 21,410 102,167 (0%) 0% 160.1 3,428,169 Common Stock
Albert J. Robichaud Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 159.46 per share. 14 Dec 2017 8,734 123,577 (0%) 0% 159.5 1,392,724 Common Stock
Albert J. Robichaud Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 158.18 per share. 14 Dec 2017 16,748 132,311 (0%) 0% 158.2 2,649,199 Common Stock
Asha Nayak None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Nov 2017 20,883 20,883 - - Stock Options (Right to buy)
Kevin P. Starr None Other type of transaction at price $ 0.00 per share. 27 Sep 2017 545,000 547,916 (1%) 1% 0 Common Stock
Kevin P. Starr None Other type of transaction at price $ 0.00 per share. 18 Jul 2017 800,000 1,092,916 (2%) 2% 0 Common Stock
James M. Frates None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2017 14,000 14,000 - - Stock Option (Right to Buy)
Steven M. Paul None 07 Jun 2017 14,000 14,000 - - Stock Option (Right to Buy)
Geno J. Germano None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2017 14,000 14,000 - - Stock Option (Right to Buy)
Kevin P. Starr Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2017 14,000 14,000 - - Stock Option (Right to Buy)
Michael F. Cola None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2017 14,000 14,000 - - Stock Option (Right to Buy)
Michael Cloonan Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2017 185,000 185,000 - - Stock Option (Right to Buy)
Anne Marie Cook See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 56,000 56,000 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 140,000 140,000 - - Stock Option (Right to Buy)
Kimi Iguchi CFO & Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 45,000 45,000 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 40,000 40,000 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 40,000 40,000 - - Stock Option (Right to Buy)
Thomas Anderson See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2017 40,000 40,000 - - Stock Option (Right to Buy)
Steven M. Paul None 31 Jan 2017 2,174 690,851 (1%) 0% 3.1 6,848 Common Stock
Kevin P. Starr None Other type of transaction at price $ 0.00 per share. 23 Jan 2017 1,000,000 1,892,916 (5%) 2% 0 Common Stock
Kimi Iguchi CFO, Secretary and Treasurer Sale of securities on an exchange or to another person at price $ 53.92 per share. 13 Jan 2017 10,000 66,498 (0%) 0% 53.9 539,200 Common Stock
Thomas Anderson See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2016 1,900 165,138 - - Stock Option (Right to Buy)
Thomas Anderson See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2016 1,900 1,900 - - Common Stock
Thomas Anderson See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 15 Dec 2016 346 1,554 - - Common Stock
Kimi Iguchi CFO, Secretary and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2016 14,400 68,000 - - Stock Option (Right to Buy)
Anne Marie Cook General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2016 10,000 40,000 - - Stock Option (Right to Buy)
Jeffrey M. Jonas Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2016 43,200 324,000 - - Stock Option (Right to Buy)
Stephen J. Kanes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2016 14,400 68,000 - - Stock Option (Right to Buy)
Albert J. Robichaud Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 08 Dec 2016 250 154,759 - - Common Stock
Albert J. Robichaud Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 08 Dec 2016 250 155,009 - - Common Stock
Albert J. Robichaud Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 08 Dec 2016 250 155,259 - - Common Stock
Albert J. Robichaud Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 08 Dec 2016 250 154,259 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters